Northpond Ventures

United States
Northpond Ventures is a science-driven venture capital firm headquartered in Bethesda, Maryland. Our mission is to build a better tomorrow. Our investments are focused on life sciences, technology, and affiliated industries.
Founded:2018
Firm Location:United States • Massachusetts • Maryland • New York, New York • San Diego, California • San Francisco, California • Washington, District of Columbia • Boston, Massachusetts • Cambridge, Massachusetts • San Francisco Bay Area • Washington, D.C.
Northpond Ventures Team
Photo of Diana Bernstein, Vice President at Northpond Ventures
Diana Bernstein
Northpond Ventures·Vice President
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA)
Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Karthik Bolisetty, Associate at Northpond Ventures
Karthik Bolisetty
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Photo of Tiffany Chen, Associate at Northpond Ventures
Tiffany Chen
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA)
Photo of Shaan C. Gandhi, Managing Director at Northpond Ventures
Shaan C. Gandhi
Northpond Ventures·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Andrea Jackson, Managing Director at Northpond Ventures
Andrea Jackson
Northpond Ventures·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Daniel Janse, Managing Director at Northpond Ventures
Daniel Janse
Northpond Ventures·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA)
Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Sharon Kedar, Partner at Northpond Ventures
Sharon Kedar
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Washington (D.C.)
Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Washington, D.C. (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Andrew Lee, Senior Associate at Northpond Ventures
Andrew Lee
Northpond Ventures·Senior Associate
Sweet spot: $10
Range: $1 - $40
Investors in Washington (D.C.), Investors in San Francisco (CA)
Investors in Drug Delivery (Series B), Investors in Chemicals (Series B), Investors in Chemicals (Series B), Investors in Chemicals (Seed), Investors in Chemicals (Series A), Investors in Drug Delivery (Series B), Investors in AgTech (Series B), Investors in Drug Delivery (Seed), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Chemicals (Series A), Investors in Pharmaceuticals (Series B), Investors in Drug Delivery (Series B), Investors in BioTech (Series B), Investors in Chemicals (Seed), Investors in AgTech (Series A), Investors in AgTech (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Washington, D.C. (Other Lists), Investors in Chemicals (Series B), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in AgTech (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Chemicals (Series A), Investors in BioTech (Series A), Investors in Chemicals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in AgTech (Series A), Investors in Diagnostics (Series B), Investors in Diverse Investors (Other Lists), Investors in AgTech (Seed), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in BioTech (Series B), Investors in AgTech (Series B), Investors in Pharmaceuticals (Series B), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in AgTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Lily Li, Principal at Northpond Ventures
Lily Li
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Diego (CA)
Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Los Angeles / Southern California (Other Lists)
Photo of Paxton Major, Senior Associate at Northpond Ventures
Paxton Major
Northpond Ventures·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Washington (D.C.), Investors in Cambridge (MA)
Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Washington, D.C. (Other Lists), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Patrick Malone, Principal at Northpond Ventures
Patrick Malone
Sweet spot: $850K
Range: $700K - $1M
Investors in Washington (DC)
Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in AI (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in AI (Seed), Investors in Health IT (Seed), Investors in Washington, D.C. (Other Lists), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in AI (Series A), Investors in Health IT (Seed), Investors in AI (Seed)
Photo of Maddie Maloney, Analyst at Northpond Ventures
Maddie Maloney
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Massachusetts
Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Nemo Marjanovic, Senior Associate at Northpond Ventures
Nemo Marjanovic
Northpond Ventures·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Connor McDermott, Associate at Northpond Ventures
Connor McDermott
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in BioTech (Series A), Investors in Boston / New England (Other Lists), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Merouane Ounadjela, Analyst at Northpond Ventures
Merouane Ounadjela
Sweet spot: $10
Range: $5 - $30
Investors in San Francisco (CA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in Diagnostics (Series B), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in DeepTech (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in BioTech (Series B), Investors in DeepTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists)
Photo of Marc Rosenberg, Analyst at Northpond Ventures
Marc Rosenberg
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Photo of Michael Rubin, Investor at Northpond Ventures
Michael Rubin
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Maryland
Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Adam Wieschhaus, Managing Director at Northpond Ventures
Adam Wieschhaus
Northpond Ventures·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA), Investors in San Francisco (CA)
Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Camella Wilson, Vice President at Northpond Ventures
Camella Wilson
Northpond Ventures·Vice President
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United States